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Abstract
Background
The objective was to determine whether
variation in laboratory utilization exists
and whether physicians were responsible
for a portion of this variation.
Method
Variation in laboratory test ordering
was collected on subspecialty services:
the Medical Intensive Care Unit (MICU)
and the Oncology Service. Ordinary
least-squares regression was used to
determine the effect of interns, residents,
and attendings on the variation observed.
Results
Variation in laboratory utilization
attributable to physicians exists.
Housestaff explain a proportion of this
variation on each subspecialty service.
Conclusions
Housestaff explain a large proportion of
laboratory utilization attributable to
physicians. This may represent an
opportunity for education on systems-
based practice and practice-based learning.
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Although graduate medical education
(GME) is subsidized by several sources,
there remains substantial concern about
the added costs of care provided by
physicians-in-training. Increased costs
result not only from the tendency of less
experienced physicians to order more
testing than more seasoned physicians1
but also because residents may order labs
more variably and less in response to clear
clinical indications. This variation can itself
induce costs by requiring extra capacity to
accommodate those swings in demand. In
an era of increasing concerns about the
fiscal viability of academic medical centers,
reducing variation in laboratory utilization
may lessen the costs of GME.
Understanding variations of laboratory
utilization, however, may have other
impacts on GME. Physicians-in-training
receive little information regarding their
own practice pattern. Improved knowledge
about their own practice patterns and
hospital costs might reduce resource
utilization and better prepare
physicians-in-training for today’s health
care market. In fact, the Accreditation
Council for Graduate Medical Education
(ACGME) included practice-based
learning and improvement (PBLI) and
systems-based practice (SBP) in the six
core competencies at the heart of resident
education2— competencies that directly
reflect resident self-conscious awareness
of their own patterns of testing and other
resource utilization.
Although many medical educators
suspect that trainee variation may
induce extra variation in practice, the
specific patterning of this has not been
well studied. Does significant variation
in resource utilization between
admissions that cannot be explained by
clinical characteristics of patients exist?
If so, what proportion of this variation
can be explained by the intern or
resident as opposed to the practice
patterns of the attending of record? If
such variation exists, it is likely to be of
little benefit to the patient and can be a
target for future educational interventions
to not only increase the knowledge of
physicians-in-training about PBLI and SBP
but also potentially reduce the cost of GME.
The purpose of the study was to test
the following hypothesis: There exists
variation in laboratory utilization
between patient-days on three
subspecialty services that is attributable
to the identity of particular care team




This study was conducted at the Hospital
of the University of Pennsylvania (HUP),
a tertiary-care academic medical center,
after approval by the institutional review
board (IRB). Data on laboratory
utilization were collected between June of
2007 and January of 2008. Laboratory
data of patients on the Oncology Service
and in the Medical Intensive Care Unit
(MICU) were collected.
The Oncology Service is divided into
teams caring for patients with
hematologic (Liquid Oncology) and
solid (Solid Oncology) malignancies.
The teams on the Oncology Service are
composed of interns under the
supervision of a resident and an oncology
attending. The MICU at HUP is a 24-bed
unit. We examined medical teams of the
same structure as on the Oncology
Service—interns under the supervision of
a resident who, in turn, is supervised by
an attending physician.
Provider identification and schedule
Once the patient is admitted, the intern
assigns the patient to him- or herself
electronically. Because the end-of-shift
sign-out system is predicated on this
electronic assignment, compliance is high
and self-policed. This information is then
matched with the electronic scheduling
system used by the medicine department
at HUP to identify the senior resident
and attending physician involved in the
care of the individual patient on that day.
Interns and residents typically rotate on
each service for one month and are on
call every third night in the MICU and
Correspondence: C. Jessica Dine, MD, 3400 Spruce
Street, 8 Gates, Philadelphia, PA 19104; e-mail:
(jessica.dine@uphs.upenn.edu).
Academic Medicine, Vol. 84, No. 10 / October 2009 Supplement S63
every fourth night on the Oncology
Service. The attending physician coverage
is typically for 14 days. MICU attending
physicians are on call each night, whereas
oncology attending physicians cover calls
every other night. During the eight months
of data collection, interns, residents, and
attending physicians rotate frequently.
Interns and residents rotate every four
weeks but are offset by one week.
Furthermore, attendings rotate every two
weeks. These frequent and offset
rotations allow for distinct team
configuration and, thus, statistical
identification of variance of laboratory
utilization by provider type.
Laboratory utilization
A patient-day was defined as a period
from noon to noon. This accounts for the
fact that most of the morning laboratory
orders were actually placed the evening
prior to that day. Labs ordered or
collected in the Emergency Department,
in the outpatient setting, or by another
department before transfer to medicine
were excluded from the analysis. Labs
were only assigned to the MICU team if
they were ordered during the MICU
stay. Likewise, MICU laboratory tests
were excluded for the Oncology
Service. The patient-day was assigned
to the ICU if the patient spent the
majority of the day in the ICU.
Laboratory tests were aggregated into
composite laboratory tests if they were
ordered at the same time. For example,
white blood cell count, hemoglobin, and
platelet count were aggregated into a
single laboratory test of a complete blood
count, even if they were ordered
separately, as long as they were drawn
together. Point-of-care fingersticks for
blood glucose levels were excluded
because these are routinely done by
nursing without physician scheduling.
The laboratory costs were calculated
using the marginal variable supply
costs obtained from the hospital
cost-accounting system.
Statistical analysis
Ordinary least-squares regression was
used for the analysis to explain the
variance in laboratory utilization by
provider type.3 The overall explained
variation was defined as the R2 for a
model containing the appropriate
provider type. Patients were cared for by
a primary intern under the supervision of
a resident and an attending. The
contribution of each provider type to the
variance in laboratory utilization was
calculated by dividing the difference of
the R2 of the models including and
excluding the provider type by the overall
explained variation. Bootstrapping by
taking 1,000 repeated samples with
replacement from the observed
population of patient-days at the patient
level was performed for confidence
intervals.4,5 Sequential F testing was
performed as a complementary approach
to detect whether adding one provider
type to the model already containing the
other two would increase the explanatory
power of the model. Data were analyzed




During data collection, 23 interns, 15
residents, and 17 attending physicians
served on the Liquid Oncology Service.
There were 123 patients with 188 total
hospitalizations comprising 1,598
patient-days. Characteristics of patients,
resource utilization, patient outcomes,
and providers are shown in Table 1.
Team composition alone on the liquid
oncology service explained 11.1% of
variation between non-ICU patient-days
in lab utilization. The attending
explained 14.0% (95% CI: 9.8%, 27.3%)
of that team-effect variation, with 20.8%
(95% CI: 12.5%, 30.5%) explained by
the resident and 37.3% (95% CI: 26.5%,
48.2%) by the intern. The remainder could
not be attributed to any member of the team.
Solid oncology
Thirty-three interns, 18 residents, and 23
attending physicians rotated on the Solid
Oncology Service. Five of these interns
and one of the residents had also rotated
on the Liquid Oncology service during
data collection. There were 431
hospitalizations of 302 patients with a
total of 2,322 patient-days. On this
service, 7.4% of the overall variation in
laboratory use could be explained by
providers as opposed to patients.
Attendings accounted for 21.9% (95%
CI: 14.5%, 35.2%) of the explained
variation in daily laboratory ordering,
residents 15.0% (95% CI: 8.2%, 25.0%),
and interns 45.0% (95% CI: 32.2%,
55.1%). The remaining 18.1% could not
be uniquely attributed to any team
member.
For both oncology services, a
complementary approach was used to
detect whether adding one provider type
to the model already containing the other
two would increase the explanatory
power of the model, as measured by
sequential F testing. For any
combination, the explanatory power was
increased each time until both attending
physicians and interns were in the model.
However, if both of these provider types
were already in the model, adding
residents no longer increased the
explanatory power.
Medical intensive care unit
Data were collected on 270 patients who
were covered by 22 interns, 22 residents,
and 14 attendings during 286
hospitalizations for a total of 1,247 ICU
patient-days. Thirteen of these interns
had also rotated on the Liquid and Solid
Oncology services. There was no overlap
of residents or attending physicians.
Patient characteristics and data on
resource utilization including average
number and costs of laboratory tests
ordered in the MICU are shown in Table
1. For patients cared for by an intern
under the supervision of a senior resident
and an attending, the team explained
12.5% of the day-to-day variation in lab
utilization. The attending explained
11.8% (95% CI: 6.1%, 25.6%) of the
variation, and the resident explained
26.3% (95% CI: 15.8%, 39.4%). The
intern accounted for 25.6% (95% CI:
13.0%, 39.1%), and 36.3% could not be
uniquely attributed to any team member.
Sequential F tests confirmed that each
provider type added explanatory value to
a model already containing the other two.
Discussion
Variation in laboratory utilization
between patient-days on three
subspecialty services exists. The identities
of the caring physicians explain a
proportion of this variation (11.1%,
7.4%, and 12.5% for the Liquid
Oncology, Solid Oncology, and MICU
services, respectively). Although this is a
modest proportion of the overall
variation observed, it has no clear
benefits for patients and may be
amenable to intervention. It represents
substantial variable costs that are directly
removed from the financial margins of
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medical centers. Housestaff are
responsible for a portion of the variation
attributable to physicians. This may
represent an opportunity for quality
improvement and cost containment at
academic health centers via strategies to
reduce such variation.
Some investigators have suggested that
physician personal attributes, such as
age and gender, affect their ordering
profiles.6 However, physician
understanding and knowledge of
current guidelines have also been
shown to contribute to the variation.7
By understanding the etiologies of such
variation, it may be possible to reduce
it in laboratory ordering through
improvements in medical training and
education. In particular, educational
interventions may increase the
knowledge of physicians-in-training
about their resource utilization and
provide an opportunity for formal
training on PBLI and SBP as mandated
by the ACGME. This could also improve
the efficiency of their practice.
The variation in laboratory utilization
may also present a possibility to improve
the teaching and supervision of medical
residents. To minimize variation in
resource utilization, any intervention will
have to be aimed at the health care team
with particular attention to the
predominant driver in resource
utilization. Interns may have the
predominant impact on variations of
laboratory utilization in our case. This
impact seems to decrease with increases
in the level of attending supervision. For
these three services at HUP, the level of
supervision increases in the following
order: Solid Oncology ! Liquid
Oncology ! MICU. The interns on these
services explained 45%, 37%, and 26%,
respectively, of the variation in laboratory
ordering. Future studies will have to be
done to determine whether these means
in proportion of team variation explained
by interns were significantly different
across these three services.
Understanding variations in resource
utilization may also lead to cost
containment while improving quality of
care provided. For example, variations in
laboratory ordering may result in
unnecessary work-ups of false-positive
tests.8,9 The investigators of one study
published more than 30 years ago
demonstrated that a large variation in
laboratory utilization existed among
similarly trained physicians caring for
similar patients.10 Later, they
demonstrated that there was a strong
correlation between an intern’s overall
cost rank among his or her peers and the
number of unnecessary tests ordered.11
This is a single-center study. The
variation between patient-days may differ
Table 1
Results Based on Service*
Results Liquid oncology Solid oncology MICU service
Mean (SD) patient age in years 58 (13) 62 (14) 61 (15)
Percentage female patients (%) 47 54 45
Race of patients (%)
...................................................................................................................................................................................................................................................................................................................
Caucasian 37 7 2
...................................................................................................................................................................................................................................................................................................................
Black 14 34 45
...................................................................................................................................................................................................................................................................................................................
Other 11 1 1
...................................................................................................................................................................................................................................................................................................................
Unknown 38 58 52
Mean (SD) patient Charlson Index score† 2.5 (1.1) 3.7 (2.3) 2.6 (1.5)
Median (IQR) length of stay (days) 20 (9–33) 7 (4–14) 19 (8–25)
Mean (SD) no. of labs per day 11.6 (7.7) 6.5 (6.3) 18.5 (13.5)
Median (IQR) no. of labs per day 101 (7–15) 6 (1–9) 15 (10–24)
Mean (SD) cost in dollars of daily labs 38.00 (23.50) 16.70 (21.20) 40.10 (36.10)
Median (IQR) cost in dollars of daily labs 23.00 (11.00–41.00) 10.00 (0.00–23.00) 32.00 (17.00–54.00)
No. of providers
...................................................................................................................................................................................................................................................................................................................
Interns 23 33 22
...................................................................................................................................................................................................................................................................................................................
Residents 15 18 22
...................................................................................................................................................................................................................................................................................................................
Attendings 17 23 14
Total variation in labs explained by team (%) 11.1 7.4 12.5
...................................................................................................................................................................................................................................................................................................................
Proportion of variation attributable to team explained
by interns (95% CI)
37.3 (26.5, 48.2) 45.0 (32.2, 55.1) 25.6 (13.0, 39.1)
...................................................................................................................................................................................................................................................................................................................
Proportion of variation attributable to team explained
by residents (95% CI)
20.8 (12.5, 30.5) 15.0 (8.2, 25.0) 26.3 (15.8, 39.4)
...................................................................................................................................................................................................................................................................................................................
Proportion of variation attributable to team explained
by attending (95% CI)
14.0 (9.8, 27.3) 21.9 (14.5, 35.2) 11.8 (6.1, 25.6)
* IQR indicates interquartile range; MICU, Medical Intensive Care Unit. Patients with hematologic malignancies are
assigned to the Liquid Oncology Service, whereas those with solid malignancies are placed on the Solid
Oncology Service.
† The Charlson Index creates a weighted index based on the number and seriousness of comorbidities and
provides a measure of risk of death from comorbid disease.
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at other institutions. A direct link
between variation in laboratory
utilization and the quality of care
provided has not been made. Future
work will investigate this further. The
amount of physician contribution to
the overall variation in laboratory
ordering is small. However, it may
present a target for future interventions,
may be a visible signal of many similar
practice variations throughout processes
of care, and may still provide a
mechanism for potentially large cost
reduction.
Conclusions
Variation exists in laboratory utilization
between patient-days attributable to
physicians on three subspecialty services.
Housestaff explain a large proportion of
this variation. This may represent an
important opportunity for quality
improvement and cost containment at
academic health centers via strategies
to reduce such variation while
simultaneously addressing the ACGME
core competencies of systems-based
practice and practice-based learning.
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